Toronto Ottawa Heart Summit - Heart Failure Update


Program Agenda (2022)


Who should attend:

  • Cardiovascular specialists
  • Internists
  • Allied health professionals
  • Heart failure care teams
  • Cardiovascular Trainees, Residents and Fellows
  • Basic scientist interested in CV disease
  • Primary care providers

Now Open: Call for Abstracts

Overall Program Learning Objectives

At the end of the program, participants will be able to:

  • Elicit and accurately synthesize relevant research data for the purpose of diagnosing and managing patients with complex cardiovascular disease (Scholar, Medical Expert)
  • Demonstrate improved understanding of best practice clinical scenarios for patients with multiple co-morbidities and CV disease (Professional, Health Advocate)
  • Seek appropriate consultation from others as required, recognizing the limits of their own clinical expertise (Collaborator, Communicator)
  • Contribute to the dissemination, application and translation of new knowledge and practices to peers and other professionals (Professional, Manager)


Upon completion of this program participants should be able to:

  • Recognize current and emerging advancements in CV Risk Prediction
  • Demonstrate improved understanding of cardiovascular health through exercise
  • Recognize the Long-term Cardiovascular Consequences of COVID-19
  • Choose appropriate cardiac imaging in the diagnosis and management of cardiovascular involvement caused by as a sequalae of COVID infection or vaccination
  • Select the appropriate antithrombotic treatment for patients with Atrial fibrillation
  • Identify best practices for the management of patients with atrial fibrillation
  • Illustrate the current recommendations of the Canadian Cardiovascular Society Guidelines for Rate and Rhythm Control Options for atrial Fibrillation
  • Determine a practical approach to current and emerging evidence in the diagnosis and management of spontaneous coronary artery dissection
  • Outline a practical approach to current and emerging evidence in the diagnosis and management of MI with non-obstructive coronary arteries
  • Delineate Strategies for Disease in Women, Improving Risk Stratification, Diagnosis, and Management from a Gender Perspective
  • Recognize Presentation and Management of Acute Cardiovascular Complications in Pregnancy
  • Summarize current and upcoming advanced treatment strategies in Heart Failure with preserved ejection fraction
  • Identify a practical approach to better manage and improve outcomes in patients with heart failure and reduced ejection fraction
  • Select the current and emerging devices and remote monitoring platforms that are available to aid in the diagnosis and management of heart failure
  • Explain the Long-Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients with Heart Failure
  • Examine efficacy of cardiac myosin inhibitor mavacamten, to reduce the need for invasive septal reduction therapies in patients with advanced hypertrophic obstructive cardiomyopathy
  • Learn the rationale, methods and results of a large trial on perioperative management of blood pressure and antihypertensive medications
  • Recognize the balance, maximizing your gain and minimizing loss when using an SLGT 2 inhibitor
  • Discuss new insights into the management of a complex Cardiomyopathy case
  • Discuss new insights into the management of patients with coronary artery disease
  • Choose medical management of diabetes based on the current guidelines
  • Identify LDL lowering targets in patients with cardiovascular disease with and utilization of non statin interventions
  • Recognize and understanding the burden of obesity and the cardiovascular impact with the utilization of novel therapies for weight reduction
  • Explain the anatomy and disease process that affects the Aortic, Mitral and Tricuspid valve
  • Determine best treatment options for patients with Aortic, Mitral and Tricuspid valve disease
  • Recognize the limitations and cautions to proceeding with a valvular transcatheter intervention
  • Recognize the importance and effect of frailty on patients with cardiovascular disease
  • Determine how imaging in cardio oncology can aid in the early diagnosis and identification and follow up in patients receiving chemotherapy whom are at risk of ventricular dysfunction
  • Describe the emerging therapies in the management of Diabetic Kidney Disease, benefits , indications and limitations

Last Update: June 12, 2022

* Virtual Presentation.

Day 1

Friday, June 24, 2022

  THEME: Resolving 0ngoing Controversies in Cardiovascular Disease
11:15 Welcome Remarks
Drs. Michael Farkouh and Peter Liu
  Session 1: Prevention/ Pandemic Impact on CV Health
Chair: Dr. Peter Liu
11:25 Cardiology trainee case presentation - Dr. Tahir Kafil
11:30 Risky Behaviour: Challenges and Pitfalls of Risk Prediction
Dr. Neil Stone *
11:45 Exercise for CV Health: How Much is Good Enough or Too Much?
Dr. Jack Goodman
12:00 Long-term Cardiovascular Outcomes of COVID-19?
Dr. Betty Raman *
12:15 Cardiac Imaging in Myocarditis: COVID-19, Post-Vaccination and Beyond
Dr. Kate Hanneman
12:30 Panel discussion
12:50 LUNCH and Satellite Symposium 1 (click here)
  Session 2: Atrial Fibrillation
Chair: Dr. L. Brent Mitchell
2:00 Cardiology trainee case presentation- Dr. Laurie-Anne Boivin-Proulx
2:05 Anticoagulation in AF: Managing Your High-Risk AF Patients in Clinical Practice
Dr. Andrew Ha
2:20 Introduce George Wyse Memorial Lecture
Dr. L. Brent Mitchell
2:25 George Wyse Lecture - Rhythm Control in Atrial Fibrillation
Dr. Jason Andrade *
2:40 Risk Factor to Control Rate and Rhythm
Dr. Isabelle Nault
2:55 Panel discussion
3:10 Break
  Session 3: Women & Heart Disease
Chair: Dr. Candice Silversides *
3:30 Cardiology trainee case presentation - Dr. Angel Fu
3:35 SCAD
Dr. Jacqueline Saw *
Dr. Thais Coutinho
4:05 The Emerging Field of CardioObstetrics
Dr. Candice Silversides *
4:20 Panel discussion
4:35 Wine & Cheese Poster Session
6:00 Adjournment
Day 2

Saturday, June 25, 2022

  THEME: Resolving 0ngoing Controversies in Cardiovascular Disease
7:15 Satellite Symposium 2 (click here)
8:20 Welcome Remarks
Drs. Michael Farkouh and Peter Liu
  Session 4: Heart Failure
Chair: Drs. Javed Butler* and Harriette Van Spall
8:30 Cardiology trainee case presentation - Dr. Ismail Raslan
8:35 Update on HFpEF
Dr. Mikhail Kosiborod *
8:50 HFrEF: The Many Paths to HF Optimization
Dr. Peter Liu
9:05 Devices for HF
Dr. Javed Butler *
9:20 Panel discussion
9:40 Health break
  Session 5: Late Breakers from ACC
Chair: Drs. Michael Farkouh and Peter Liu
10:05 Sodium HF Trial
Dr. Justin Ezekowitz
10:20 POISE-3 Trial
Dr. Maura Marcucci
10:35 VALOR-HCM Trial
Dr. Arnon Adler
10:50 Panel discussion
  Session 6: Stump the Experts
Chair: Drs. Justin Ezekowitz, Matt Luther, Jean-Francois Tanguay* and Satya Dash
11:10 Case 1: Shifting Paradigms - When to Sweeten the Heart Pump
Dr. Varinder Randhawa (Fellow in Critical Care Medicine)
11:25 Case 2: When the Aortic Valve Gets in the Way
Dr. Marianne Tétreault-Langlois (Cardiology Resident)
11:40 Case 3: Blood Pipes and Shunts
Dr. Kenza Rahmouni (Cardiac Surgery Resident)
11:55 Panel discussion
12:15 LUNCH (Trainees meet the Experts)
  Session 7: Diabetes/Lipids
Chair: Drs. Satya Dash and Ruth McPherson
1:30 Cardiology trainee case presentation - Dr. Amelie Paquin
1:35 Pragmatic Comparative Effectiveness Trial of SGLT2i, GLP-1RA in Patients with Diabetes and ASCVD
Dr. Brendan Everett *
1:50 Changing the Paradigm on LDL Lowering
Dr. Scott Wright
2:05 Novel Medical Therapies for Obesity
Dr. Satya Dash
2:20 Panel discussion
  Session 8: Valves
Chair: Drs. David Messika-Zeitoun and Anita Asgar
2:35 Cardiology trainee case presentation - Dr. Najah Adreak
2:40 Updates on Transcatheter AV Replacement
Dr. Talal Al-Atassi
2:55 Transcatheter Mitral Valve Replacement: Latest Advances
Dr. Jean-Michel Paradis
3:10 Transcatheter Tricuspid Intervention-No Longer the Forgotten Valve
Dr. Neil Fam *
3:25 Panel discussion
3:45 Health Break
  Session 9: Challenging Cases
Chairs: Drs. Stephen Gottlieb and Maura Marcucci
4:15 Cardiology trainee case presentation - Dr. Maude Roberge
4:20 Fraility Debunked: The Right Frailty Test for the Right Patient at the Right Time
Dr. Jonathan Afilalo
4:35 New Treatment Advances-Amyloid Heart Disease
Dr. Stephen S. Gottlieb
4:50 Diabetic Kidney Disease: Where’s Aldo? Understanding Novel Treatment Approaches in DKD
Dr. Matt Luther
5:05 Panel discussion
5:20 3 high ranked posters: Rapid Fire Oral presentation & awards
5:40 Closing Remarks & Adjournment

(click on a button to view an agenda)


About us

The Toronto Ottawa Heart Summit has held successful symposia for the last 19 years. Join us at our next event where we will celebrate our 20th anniversary.

Opt-in/Opt-out of Email Lists

In compliance with anti-spam initiatives: